The Business Research Company The Business Research Company's Bruton's Tyrosine Kinase (BTK) Inhibitor Global Market Report 2025 – Market S ...

WICHITA, Kan. (KWCH) - On August 18, 2005, 20 years ago, a Sedgwick County judge sentenced Dennis Rader, also known as the ...

Mesutoclax is a novel, orally bioavailable BCL2 selective inhibitor. BCL2 is an important regulatory protein in the apoptosis pathway, and its abnormal expression is associated with the development of ...

In 1974, Charlie Otero came home to find his family murdered by the BTK killer. Three decades later, he finally looked the ...

"I wanted to create an effective way to alert a jug fisher when a fish had been caught and its location," said an inventor, ...

InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that the ...

Panelists discuss how providers and payers must collaborate to develop innovative coverage criteria for BTK inhibitors that ...

EMA grants orphan designation to Sanofi’s rilzabrutinib, a reversible covalent BTK inhibitor, for IgG4-related disease: Paris Saturday, August 16, 2025, 09:00 Hrs [IST] Sanofi a ...

The professor who once taught Bryan Kohberger is still haunted by his crimes and wants answers the court never uncovered.

Oncology company BeOne Medicines' investigational Bruton's tyrosine kinase (BTK) degrader, BGB-16673, has received priority medicines (PRIME) designation from the European Medicines Agency (EMA ...

Under threat of potential closure, a local nonprofit is trying to raise money for repairs to keep the historic site open to visitors.

TEL AVIV, Israel (AP) — Israel gave final approval Wednesday for a controversial settlement project in the occupied West Bank ...